Korea Arlico Pharm Co (XKRX:260660) ROCE % : 1.83% (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Korea Arlico Pharm Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Korea Arlico Pharm Co's annualized ROCE % for the quarter that ended in Dec. 2024 was 1.83%.

Korea Arlico Pharm Co ROCE % Historical Data

The historical data trend for Korea Arlico Pharm Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Arlico Pharm Co ROCE % Chart

Korea Arlico Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

12.55

6.90

10.20

5.08

-4.06

Korea Arlico Pharm Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-10.93	-6.08	-17.29	5.16	1.83

Korea Arlico Pharm Co ROCE % Calculation

Korea Arlico Pharm Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	-4069.185	/	( ( (173477.422 - 70319.988)	+	(172363.118 - 75195.088) )	/ 2 )
	=	-4069.185	/	( (103157.434	+	97168.03)	/ 2 )
	=	-4069.185	/	100162.732
	=	-4.06 %

Korea Arlico Pharm Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	1791.816	/	( ( (164222.33 - 65255.185)	+	(172363.118 - 75195.088) )	/ 2 )
	=	1791.816	/	( ( 98967.145	+	97168.03 )	/ 2 )
	=	1791.816	/	98067.5875
	=	1.83 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

Korea Arlico Pharm Co (XKRX:260660) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Korea Arlico Pharm Co ROCE % Related Terms

Thank you for viewing the detailed overview of Korea Arlico Pharm Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Korea Arlico Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Arlico Pharm Co Ltd (XKRX:260660) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

7-21, Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR

Website

http://www.arlico.co.kr

Korea Arlico Pharm Co Ltd is engaged in the business of manufacturing and selling pharmaceuticals products. The company offers products in the area of the circulatory system, antiplatelet, muscle relaxants, diabetes, antibiotic and chemotherapy, allergy and respiratory disease, ointment, vitamin and health supplements, digestive system, and metabolic disease. It provides products in various forms such as tablets, capsules, gel, and cream.

Korea Arlico Pharm Co Headlines

No Headlines